Top

Published in:

01-05-2016 | Review Article

Hematopoietic Stem Cell Transplantation for Primary Immune Deficiency Disorders

Authors: Neena Kapoor, Revathi Raj

Published in: Indian Journal of Pediatrics | Issue 5/2016

Abstract

Hematopoietic stem cell transplantation provides a curative option for children with primary immune deficiency disorders. Increased awareness and rapid diagnosis of these conditions has resulted in early referral and the chance to offer a curative option for affected children. Management of these children involves a multidisciplinary team including infectious disease specialists and intensivists. The use of reduced intensity conditioning chemotherapy, advances in detection and therapy of viral and fungal infections, optimal supportive care and techniques in stem cell processing, including T cell depletion has enabled doctors to transplant children with co-morbid conditions and no matched donors. Transplantation for these children has also brought in deep insights into the world of immunology and infectious diseases.

Gatti R, Meuwissen H, Allen H, Hong R, Good R. Imunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet. 1968;2:1366–9.CrossRefPubMed

Bach FH, Albertini RJ, Joo P, et al. Bone-marrow transplantation in a patient with the Wiskott–Aldrich syndrome. Lancet. 1968;2:1364–6.CrossRefPubMed

Parkman R, Gelfand EW, Rosen FS, et al. Severe combined immunodeficiency and adenosine deaminase deficiency. N Engl J Med. 1975;292:714–9.CrossRefPubMed

O’Reilly RJ, Dupont B, Pahwa S, et al. Reconstitution in severe combined immunodeficiency by transplantation of marrow from an unrelated donor. N Engl J Med. 1977;297:1311–8.CrossRefPubMed

Reisner Y, Kapoor N, Kirkpatrick D, et al. Transplantation for severe combined immunodeficiency with HLA-A, B, D, DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells. Blood. 1983;61:341–8.PubMed

Kapoor N, Kirkpatrick D, Blaese RM, et al. Reconstitution of normal megakaryocytopoiesis and immunologic functions in Wiskott-Aldrich syndrome by marrow transplantation following myeloablation and immunosuppression with busulfan and cyclophosphamide. Blood. 1981;57:692–6.PubMed

Fischer A, Haddad E, Jabado N, et al. Stem cell transplantation for immunodeficiency. Semin Immunopathol. 1998;19:479–92.CrossRef

Gennery AR, Slatter MA, Grandin L, et al. Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better? J Allergy Clin Immunol. 2010;126:602–10.CrossRefPubMed

Worth AJ, Booth C, Veyes P. Stem cell transplantation for primary immunodeficiency. Curr Opin Hematol. 2013;20:501–8.CrossRefPubMed

10.

Pai SSY, Cowan MJ. Stem cell transplantation for primary immunodeficiency diseases: the North American experience. Curr Opin Allergy Clin Immunol. 2014;14:521–6.CrossRefPubMedPubMedCentral

11.

Rousso SZ, Shamriz O, Zilkha A, et al. Hematopoietic stem cell transplantation for primary immune deficiencies: 3 decades of experience from a tertiary medical center. J Pediatr Hematol Oncol. 2015;37:e295–300.CrossRefPubMed

12.

Kwan A, Church JA, Cowan MJ, et al. Newborn screening for SCID and T cell lymphopenia in california: results of the first two years. J Allergy Clin Immunol. 2013;132:140–50.CrossRefPubMedPubMedCentral

13.

Buckley RH. Transplantation of hematopoietic stem cells in human severe combined immunodeficiency: longterm outcomes. Immunol Res. 2011;49:25–43.CrossRefPubMedPubMedCentral

14.

Pai SY, Logan B, Griffith LM, et al. Transplantation of severe combined immunodeficiency in 240 patients from 2000–2009. N Engl J Med. 2014;371:434–6.CrossRefPubMedPubMedCentral

15.

Ochs HD, Slichter SJ, Harker LA, et al. The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets. Blood. 1980;55:243–52.PubMed

16.

Sullivan KE, Mullen CA, Blaese RM, et al. A multi-institutional survey of the Wiskott-Aldrich syndrome. J Pediatr. 1994;125:876–85.CrossRefPubMed

17.

Ochs HD, Filipovich A, Veys P, Cowan MJ, Kapoor N. Wiskott-Aldrich syndrome: diagnosis, clinical and laboratory manifestations, and treatment. Biol Blood Marrow Transplant. 2009;15:84–90.CrossRefPubMed

18.

Filipovich AH, Stone JV, Tomany SC, et al. Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program. Blood. 2001;97:1598–603.CrossRefPubMed

19.

Moratto D, Giliani S, Bonfim C, et al. Long-term outcome and lineage-specific chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980–2009: an international collaborative study. Blood. 2011;118:1675–84.CrossRefPubMedPubMedCentral

20.

Shin CR, Kim M-O, Li D, et al. Outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome. Bone Marrow Transplant. 2012;47:1428–35.CrossRefPubMed

21.

Janeway CA, Cragi J, Davidson M, Downey W, Gitlin D, Sullivan JC. Hypergammaglobulinemia associated with severe, recurrent and chronic non-specific infection. Am J Dis Child. 1954;88:388–92.

22.

Berendes H, Bridges RA, Good RA. A fatal granulomatous disease of childhood: the clinical study of a new syndrome. Minn Med. 1957;40:309–12.PubMed

23.

Matute JD, Arias AA, Wright NA, et al. A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity. Blood. 2009;114:3309–15.CrossRefPubMedPubMedCentral

24.

Azimi PH, Bodenbender JG, Hintz RL, Kontras SB. Chronic granulomatous disease in three female siblings. JAMA. 1968;206:2865–70.CrossRefPubMed

25.

Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore). 2000;79:170–200.CrossRef

26.

Holland SM. Chronic granulomatous disease. Hematol Oncol Clin N Am. 2013;27:89–99.CrossRef

27.

Winkelstein JA, Marino MC, Johnston RB Jr, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore). 2000;79:155–69.

28.

Seger RA, Gungor T, Belohradsky BH, et al. Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985–2000. Blood. 2002;100:4344–50.CrossRefPubMed

29.

Soncini E, Slatter MA, Jones LB, et al. Unrelated donor and HLA-identical sibling haematopoietic stem cell transplantation cure chronic granulomatous disease with good long-term outcome and growth. Br J Haematol. 2009;145:73–83.CrossRefPubMed

30.

Horwitz ME, Barrett AJ, Brown MR, et al. Treatment of chronic granulomatous disease with nonmyeloablative conditioning and T-cell-depleted hematopoietic allograft. N Engl J Med. 2001;344:881–8.CrossRefPubMed

31.

Mehta B, Mahadeo KM, Shah AJ, Kapoor N, Abdel-Azim H. Improved outcomes after reduced intensity conditioning matched unrelated donor hematopoietic stem cell transplantation in children with chronic granulomatous disease. Blood. 2013;122:2272.

32.

Balashov D, Shcherbina A, Maschan M. Single-center experience of unrelated and haploidentical stem cell transplantation with TCRαβ and CD19 depletion in children with primary immunodeficiency syndromes. Biol Blood Marrow Transplant. 2015;21:1955–62.CrossRefPubMed

33.

Cicalese MP, Aiuti A. Clinical applications of gene therapy for primary immunodeficiencies. Hum Gene Ther. 2015;26:210–9.CrossRefPubMedPubMedCentral

34.

Qasim W, Gennery AR. Gene therapy for primary immunodeficiencies: current status and future prospects. Drugs. 2014;74:963–9.CrossRefPubMed

35.

Candotti F, Shaw KL, Muul L, et al. Gene therapy for adenosine deaminase-deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans. Blood. 2012;120:3635–46.CrossRefPubMedPubMedCentral

36.

Schwarzwaelder K, Howe SJ, Schmidt M, et al. Gammaretrovirus-mediated correction of SCID-X1 is associated with skewed vector integration site distribution in vivo. J Clin Invest. 2007;117:2241–9.CrossRefPubMedPubMedCentral

Title: Hematopoietic Stem Cell Transplantation for Primary Immune Deficiency Disorders
Authors: Neena Kapoor
Revathi Raj
Publication date: 01-05-2016
Publisher: Springer India
Published in: Indian Journal of Pediatrics / Issue 5/2016
Print ISSN: 0019-5456
Electronic ISSN: 0973-7693
DOI: https://doi.org/10.1007/s12098-015-2012-z

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Hematopoietic Stem Cell Transplantation for Primary Immune Deficiency Disorders

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2016

Long-Term Prognosis of Patients with Esophageal Atresia and/or Tracheoesophageal Fistula

Systemic Juvenile Idiopathic Arthritis with Amyloidosis: An Uncommon Complication with a Favourable Outcome

Guidelines for Screening, Early Diagnosis and Management of Severe Combined Immunodeficiency (SCID) in India

Erratum to: Nebulized Magnesium Sulfate in Acute Bronchiolitis: A Randomized Controlled Trial

Homozygous p.R246Q Mutation and Impaired Spermatogenesis: Long Term Follow-up of 4 Children from One Family with 5 Alpha Reductase 2 Deficiency

Acneiform Lesion: Importance of Detailed Skin Examination